Latest Bristol-Myers Squibb Stories
SAN DIEGO, Feb. 10, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
Global Pharmaceutical & Biotechnology Outlook 2014: Major US and EU report provide analysis of individual large cap companies, promising drug candidates in their late stage pipelines, competitive
SAN DIEGO, Feb. 5, 2014 /PRNewswire/ -- Ambrx Inc. today announced the appointment of Barry Greene to its board of directors. Mr.
DUBLIN, January 29, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/2qlc2k/lexicons_lx4211) has announced the addition of the "Lexicon's
CAMBRIDGE, Mass., Jan.
Research findings enable disease molecular sub-typing to lead to more informed clinical decision-making IRVING, Texas, Jan.
RARITAN, N.J., Jan. 16, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today the U.S.
QINGDAO, China and ROCKVILLE, Md., Jan. 14, 2014 /PRNewswire/ -- Synutra International, Inc.
The FDA has approved the use of a new type 2 diabetes drug called Farxiga, developed by pharmaceutical companies Bristol-Meyers Squibb and AstraZeneca.
- Withering but not falling off, as a blossom that persists on a twig after flowering.